EVEROLIMUS 0.5 MG TABLET

EVEROLIMUS
$3.7386per EA

Strength

.5 mg/1

Manufacturer

Biocon Pharma Inc.

NDC

70377007011

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

EVEROLIMUS

Approval Type

Generic (ANDA)

FDA Application

ANDA216140

On Market Since

6/2/2025

Pharmacological Classes

Cytochrome P450 2D6 Inhibitors
Cytochrome P450 3A4 Inhibitors
Decreased Immunologic Activity
Kinase Inhibitor
Protein Kinase Inhibitors
mTOR Inhibitor Immunosuppressant
mTOR Inhibitors

Price History

1W

0.0%

1M

-5.7%

3M

-6.3%

6M

-15.0%

1Y

N/A

3Y

N/A

5Y

N/A

All

-19.2%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.